We have developed a sensitive and selective screening system for finding ; -lactam antibiotics in which a mutant of Pseudomonas aeruginosa PsCSS is employed as a test organism and penicillinase and cephalosporinase as discriminating probed1). We have added, as a test organism, a mutant of Escherichia coli which lacks chromosomal t4-lactamase and the penicillin-binding protein lB and is consequently hypersensitive to N-lactam antibiotics2). We have screened for ;S-lactam antibiotics with the above agents and encountered a streptomycete, No. C-19393 Project (ISP)6). T agar, which was used additionally for characterization and for the maintenance of strain No. C-19393, was prepared as follows: Twenty grams each of oatmeal and tomato paste, and 2 g of Bovril (edible beef extract, Bovril Ltd., Burton-on-Trent) were boiled for 10 minutes in I liter of tap water and the mixture was filtered through gauze. The filtrate was adjusted to pH 7.0, made to 1 liter with tap water and supplemented with 20 g of Bacto agar (Difco Labs.. Detroit). Agar slants were prepared after autoclaving at 120°C for 15 minutes. Seed medium used for fermentation contained (g/liter): glucose 20, soluble starch 30, soybean flour 10, corn-steep liquor 10, Polypepton (Daigo Nutritive Chem., Osaka) 5, NaCl 3, and CaCO3 (precipitated) 5. Fermentation medium contained (g/liter): glucose 30, soluble starch 30, soybean meal 15, cotton-seed meal 15, K,HPO, 0.6, KH2PO4 0.25, CoCl2 0.002, and Actcol (antifoam, Takeda Chem. Ind., Osaka) 0.5. The pH of the seed and fermentation media was adjusted to pH 7.0 with 2 N NaOH before sterilization.
Assay methods Antibiotics C-19393 S: and H, were assayed by determining (l) antibacterial activity against mutants of Eschericida coli lacking chromosomal ;"i-lactarnase and penicillin-binding protein 1B2) and (2) ~-lactamase-inhibiting activity using Klebsiella pneuntoniae as described by BROWN et al.7) The minimum inhibitory concentrations were assayed by the conventional agar-dilution method using the medium described p:reviously91. The synergistic action of C-19393 S, and H, with ampicillin and cefotiam was examined by the two-fold agar-dilution method using Trypticase soy agar (BBL, Baltimore).
Chemicals
Ampici.llin is a product of our company. Cephaloridine is a product of Eli Lilly & Co. Cefotiam was prepared in our research division. Other chemicals are commercial products.
Results

Taxonomy of Strain No. C-19393
The taxonomic characterization was carried out according to the method recommended by the ISP6).
Unless otherwise specified, the cultivation temperature was 28` C.
Morphological characterization
The strain produced aerial mycelium with tufts of straight to slightly wavy spore chains; it therefore belongs to the Section Rcctus-Fle.vibilis (RF). The mature spore chains were generally long with more than 30 spores per chain. The spores were cylindrical (0.35--0.55 0.7-1.4 pin) and their surfaces were smooth (Fig. 2 ).
Cultural characteristics
The cultural characteristics observed after a 2-weeks cultivation are shown in Table 1 . The strain gave the most characteristic appearance on T agar; the color of the aerial mycelium was light grayish yellow and thus it belongs to the Yellow color-series. Neither melanin nor other soluble pigments were formed on any agar media tested.
Physic logical characteristics
The physiological characteristics are shown in Table 2 . The strain contained cell walls of type I (1_t_-diaminopimelic acid). It is unusual source. The addition of CoCl2 greatly stimulated production of the antibiotics (Fig. 3) . The antibiotics accumulated in the culture broth were isolated by chromatographic techniques, as described in the accompanying paper'). Fig. 3 . Effect of CoCl2 on the production of antibiotics. Cultivation was carried out at 30'C for 5 days in fermentation media supplemented with various levels of CoCl2. Potency was measured as ~-lactamase-inhibiting activity and is expressed relative to that in the medium which showed the maximum potency of 100. 
Antimicrobial Activities
As seen in Table 3 , both antibiotics exhibited antibacterial activities against a wide variety of Grampositive ard Gram-negative bacteria. C-19393 H2 was 8-120 times stronger than C-19393 S2. It inhibited all the tested bacteria at concentrations below 10 jig/ml and most at below I itg/ml. On the other hand, no activities were observed against fungi and yeasts. The activity of C-19393 H2 against clinically isolated bacteria resistant to 1S-lactam antibiotics was compared with that of cephaloridine.
As shown in Table 4 , C-19393 H2 was active against bacteria which were resistant to cephaloridine. subsp. cryophilus subsp. nov. can be differentiated from these as follows: S. cattleya, the producer of thienamycinlb), is a Violet color-series streptomycete with spiral spore chains. S. olivaceus, S. flavogriseus and S, fitlvissimus, the producers of olivanic acids11,16) and epithienamycins17), are Gray color-series streptomycetes. S. cremeus subsp. aurantilis, the producer of PS-518), is a Red color-series streptornycete with RA spore chains. Fermentative production of antibiotics C-19393 S2 and H2 was greatly stimulated by addition of CoCl2. This compound was also added to the fermentation media for the production of other carbapenem antibiotics, such as thienamycinll) and olivanic acids13), presumably based on the finding of similar effects. We do not know, however, through what mechanism(s) CoCl2 exerts its pronounced stimulatory effect.
C-19393 S2 is the 8-methyl derivative of MM 455011) and, like MM 4550, it strongly inhibited (3-lactamases. The antibacterial activity of C-19393 S2 was rather low. In contrast, C-19393 H2, which is the desulfonated derivative of C-19393 S2, exhibited very strong antibacterial activity against a wide variety of bacteria, including several clinical isolates resistant to Q-lactam antibiotics. The marked difference between the antibacterial activities of C-19393 H2 and S2 will be analyzed separately4). 0-19393 H2 inhibited i3-lactamases and acted synergistically in combination with ampicillin and cefotiam against ;9-lactamase-prod ucing clinical isolates, as did C-19393 S2. The activities of C-19393 S2 and H, as potentiators of ampicillin or cefotiam were variable, depending on the bacteria tested; C-19393 S2 showed a stronger effect than C-19393 H2 for some bacteria and vice versa. Such variations are probably due to the difference between the two antibiotics in ~-lactamase-inhibiting activity or in permeability.
The in vivo effectiveness of C-19393 S2 and H2 as antibacterial agents, either alone or as potentiators of classical Denicillins and cephalosnorins. is now being investigated.
